腫瘍循環器病学2020(総論)
Saved in:
| Published in | Shinzo Vol. 52; no. 12; pp. 1318 - 1323 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Japanese |
| Published |
公益財団法人 日本心臓財団
15.12.2020
Japan Heart Foundation |
| Online Access | Get full text |
| ISSN | 0586-4488 2186-3016 |
| DOI | 10.11281/shinzo.52.1318 |
Cover
| Author | 石田, 純一 |
|---|---|
| Author_xml | – sequence: 1 fullname: 石田, 純一 organization: 東京大学大学院医学系研究科 循環器内科学 |
| BackLink | https://cir.nii.ac.jp/crid/1390009095529854080$$DView record in CiNii |
| BookMark | eNo9UDtLA0EYXCSCMaa2Fiy0uLiP-_a-LTX4goCN1svuZs9siBe5S6N9SglY-PgDIgbBzs5_c1x-hqcRm5mBGYZh1kkjG2eekE1GO4xxZHvFIGS34w7wDhMMV0iTM5SRoEw2SJNCreMYcY20iyJYSikmTCnRJFuL6bx6uiu_3qr7j_L5tXqclu8vnHK6U33OFvOH3Q2ymppR4dt_3CIXR4fn3ZOod3Z82t3vRUMugEYQG-GNsoCpA2mdSRIJHG3aT1zNwgvkKAGMjVFiH7gRFryD1EiZWlCiRbaXvVkI2oUfZELVUxVVAFwhxBRpHTtYxobFxFx6fZ2HK5PfaJNPght5vTxCA9eM_2J9x7_pBibXQyO-AUNWYVc |
| ContentType | Journal Article |
| Copyright | 2020 公益財団法人 日本心臓財団 |
| Copyright_xml | – notice: 2020 公益財団法人 日本心臓財団 |
| DBID | RYH |
| DOI | 10.11281/shinzo.52.1318 |
| DatabaseName | CiNii Complete |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2186-3016 |
| EndPage | 1323 |
| ExternalDocumentID | 130008138258 article_shinzo_52_12_52_1318_article_char_ja |
| GroupedDBID | ALMA_UNASSIGNED_HOLDINGS JSF KQ8 MOJWN RJT RYH |
| ID | FETCH-LOGICAL-j2350-54a3ea9b58fc56bca776528bfd7c5283e3828655ab4868d52a3b5ec5fa66fb593 |
| ISSN | 0586-4488 |
| IngestDate | Thu Jun 26 22:59:48 EDT 2025 Wed Sep 03 06:31:01 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 12 |
| Language | Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j2350-54a3ea9b58fc56bca776528bfd7c5283e3828655ab4868d52a3b5ec5fa66fb593 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/shinzo/52/12/52_1318/_article/-char/ja |
| PageCount | 6 |
| ParticipantIDs | nii_cinii_1390009095529854080 jstage_primary_article_shinzo_52_12_52_1318_article_char_ja |
| PublicationCentury | 2000 |
| PublicationDate | 2020/12/15 2020-12-15 |
| PublicationDateYYYYMMDD | 2020-12-15 |
| PublicationDate_xml | – month: 12 year: 2020 text: 2020/12/15 day: 15 |
| PublicationDecade | 2020 |
| PublicationTitle | Shinzo |
| PublicationTitleAlternate | 心臓 |
| PublicationTitle_FL | 心臓 Shinzo |
| PublicationYear | 2020 |
| Publisher | 公益財団法人 日本心臓財団 Japan Heart Foundation |
| Publisher_xml | – name: 公益財団法人 日本心臓財団 – name: Japan Heart Foundation |
| References | 13) Khorana AA：Venous thromboembolism and prognosis in cancer. Thromb Res 2010；125(6)：490-493 16) Young AM, Marshall A, Thirlwall J, et al：Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism：results of a randomized trial(SELECT-D). J Clin Oncol 2018；36(20)：2017-2023 15) Raskob GE, van Es N, Verhamme P, et al：Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism. N Engl J Med 2018；378(7)：615-624 9) Sawaya H, Sebag IA, Plana JC, et al：Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging 2012；5(5)：596-603 14) Prandoni P, Lensing AW, Piccioli A, et al：Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002；100(10)：3484-3488 12) Touyz RM, Herrmann SMS, Herrmann J：Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events. J Am Soc Hypertens 2018；12(6)：409-425 11) Byrd JC, Brown JR, O’brien S, et al：Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia. N Engl J Med 2014；371(3)：213-223 2) Chang H-M, Moudgil R, Scarabelli T, et al：Cardiovascular complications of cancer therapy：best practices in diagnosis, prevention, and management：part 1. J Am Coll Cardiol 2017；70(20)：2536-2551 6) Guarneri V, Lenihan DJ, Valero V, et al：Long-term cardiac tolerability of trastuzumab in metastatic breast cancer：the MD Anderson Cancer Center experience. J Clin Oncol 2006；24(25)：4107-4115 3) Plana JC, Galderisi M, Barac A, et al：Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy：a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2014；27(9)：911-939 10) Lenihan DJ, Kowey PR：Overview and management of cardiac adverse events associated with tyrosine kinase inhibitors. Oncologist 2013；18(8)：900-908 4) Ewer MS, Lippman SM：Type II chemotherapy-related cardiac dysfunction：time to recognize a new entity. J Clin Oncol 2005；23(13)：2900-2902 17) Agnelli G, Becattini C, Meyer G, et al：Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med 2020；382(17)：1599-1607 8) Matsui H, Kawai T, Sato Y, et al：A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma. Int Heart J 2020；61(5)：1070-1074 1) Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al：2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J 2016；37(36)：2768-2801 7) Johnson DB, Balko JM, Compton ML, et al：Fulminant myocarditis with combination immune checkpoint blockade. N Engl J Med 2016；375(18)：1749-1755 5) Cardinale D, Colombo A, Bacchiani G, et al：Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy. Circulation 2015；131(22)：1981-1988 |
| References_xml | – reference: 17) Agnelli G, Becattini C, Meyer G, et al：Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med 2020；382(17)：1599-1607 – reference: 1) Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al：2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Eur Heart J 2016；37(36)：2768-2801 – reference: 2) Chang H-M, Moudgil R, Scarabelli T, et al：Cardiovascular complications of cancer therapy：best practices in diagnosis, prevention, and management：part 1. J Am Coll Cardiol 2017；70(20)：2536-2551 – reference: 9) Sawaya H, Sebag IA, Plana JC, et al：Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging 2012；5(5)：596-603 – reference: 15) Raskob GE, van Es N, Verhamme P, et al：Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism. N Engl J Med 2018；378(7)：615-624 – reference: 14) Prandoni P, Lensing AW, Piccioli A, et al：Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002；100(10)：3484-3488 – reference: 4) Ewer MS, Lippman SM：Type II chemotherapy-related cardiac dysfunction：time to recognize a new entity. J Clin Oncol 2005；23(13)：2900-2902 – reference: 6) Guarneri V, Lenihan DJ, Valero V, et al：Long-term cardiac tolerability of trastuzumab in metastatic breast cancer：the MD Anderson Cancer Center experience. J Clin Oncol 2006；24(25)：4107-4115 – reference: 7) Johnson DB, Balko JM, Compton ML, et al：Fulminant myocarditis with combination immune checkpoint blockade. N Engl J Med 2016；375(18)：1749-1755 – reference: 16) Young AM, Marshall A, Thirlwall J, et al：Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism：results of a randomized trial(SELECT-D). J Clin Oncol 2018；36(20)：2017-2023 – reference: 5) Cardinale D, Colombo A, Bacchiani G, et al：Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy. Circulation 2015；131(22)：1981-1988 – reference: 11) Byrd JC, Brown JR, O’brien S, et al：Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia. N Engl J Med 2014；371(3)：213-223 – reference: 12) Touyz RM, Herrmann SMS, Herrmann J：Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events. J Am Soc Hypertens 2018；12(6)：409-425 – reference: 10) Lenihan DJ, Kowey PR：Overview and management of cardiac adverse events associated with tyrosine kinase inhibitors. Oncologist 2013；18(8)：900-908 – reference: 3) Plana JC, Galderisi M, Barac A, et al：Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy：a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2014；27(9)：911-939 – reference: 13) Khorana AA：Venous thromboembolism and prognosis in cancer. Thromb Res 2010；125(6)：490-493 – reference: 8) Matsui H, Kawai T, Sato Y, et al：A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma. Int Heart J 2020；61(5)：1070-1074 |
| SSID | ssib000871993 ssib005879815 ssib058494393 ssj0000605722 ssib002822027 |
| Score | 2.2492177 |
| SourceID | nii jstage |
| SourceType | Publisher |
| StartPage | 1318 |
| Title | 腫瘍循環器病学2020(総論) |
| URI | https://www.jstage.jst.go.jp/article/shinzo/52/12/52_1318/_article/-char/ja https://cir.nii.ac.jp/crid/1390009095529854080 |
| Volume | 52 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 心臓, 2020/12/15, Vol.52(12), pp.1318-1323 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Colorado Digital library customDbUrl: eissn: 2186-3016 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000605722 issn: 0586-4488 databaseCode: KQ8 dateStart: 19690101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Ni9QwNMyuFy-iqLjqygoGlKVjJ2nSBE_pbIdFURB3YW8lTVucOcyKzl72vkcRPPgBnkVcBG_e_DfD7M_wvbQz02UFP6CE5KV9eclrX95L814IueNAwjGnwiAvoziIYhcGylUisEXItbJWFxE6Jz9-Ird3o4d7Yq_T-dTatXQwybvu8Ld-Jf_DVYABX9FL9h84u0AKAMgDfyEFDkP6VzymqaJKUJPQNKYa8ls0FTRJqTEewmgSIkRrapSHxHg_QMwWNZKBEgcKJlYkUDFAdIBLy_nyQKO0Pns-HB_uz1nj8Qxown0mgiY2PYYICymUgY6wvZjA_MaM2p3Ssx8JQLL7HkNClcGWE0ZNz1ObUAPIJTahhUdp4NpEEHTACJ_p--ehtwOquB8IwMXPImpJOqFkAHZiLYhLD8OzsgKQPrItqgVrv5KsJXh7vBHjZVOsvZjPThBM4Qzxyg9cV7Du8sFTUbfxLx9oSxwMaLVCzjGYM_BgkEdP28prjLsf28YrriQtpZuKdSsSDmh6GrQ_vlgBDMGSbCJ1zvvfxJ5CIu-fJhEUpBGYCxgHYmU8HLZ0oJ2L5EJjvGyY-k28RDoje5ncPjk6nn14Pf35dfb2-_Tjl9n7o-m3z8j2u7Mfb06O3927QnYH6U5_O2gO3ghGjIswEJHlpdW5UJUTMnc2jqVgKq-K2GEwoJIr79Bs80hJVQhmeS5KJyorZZULza-S1fH-uLxGNoTuKRdxK1ThIsdKK0A70hzskqiqCqHWyIO6X9mLOrpK1nxNWd3_TLCsx3wKo7CoRJfEbGTXyDoMRuaGmIItgxYDxlRkWoElosLrf6i_Qc4vv4KbZHXy8qBcByVzkt_yvP4FNwRWfA |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%85%AB%E7%98%8D%E5%BE%AA%E7%92%B0%E5%99%A8%E7%97%85%E5%AD%A62020%28%E7%B7%8F%E8%AB%96%29&rft.jtitle=Shinzo&rft.au=%E7%9F%B3%E7%94%B0+%E7%B4%94%E4%B8%80&rft.date=2020-12-15&rft.pub=%E5%85%AC%E7%9B%8A%E8%B2%A1%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%BF%83%E8%87%93%E8%B2%A1%E5%9B%A3&rft.issn=0586-4488&rft.eissn=2186-3016&rft.volume=52&rft.issue=12&rft.spage=1318&rft.epage=1323&rft_id=info:doi/10.11281%2Fshinzo.52.1318&rft.externalDocID=130008138258 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0586-4488&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0586-4488&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0586-4488&client=summon |